Prepregnancy creatinine, μmol/l | n = 38 | n = 33 |
Median (IQR) | 63 (55–71) | 69* (62–94) |
Prepregnancy eGFR, ml/min/1.73m2 | n = 38 | n = 33 |
Median (IQR) | 115 (100–125) | 99** (75–122) |
Prepregnancy eGFR, ml/min/1.73m2 | n = 38 | n = 33 |
< 90 | 5 (21%) | 12 (49%)*** |
< 60 | 0 | 4 (12%) |
Postpartum creatinine, μmol/l | n = 45 | n = 38 |
Median (IQR) | 62 (56–71) | 67† (58–94) |
Postpartum eGFR, ml/min/1.73m2 | n = 45 | n = 38 |
Median (IQR) | 113 (102–124) | 105‡ (71–117) |
Months followup | n = 30 | n = 31 |
Median (IQR) | 39 (23–63) | 39 (19–64) |
Fall in eGFR | n = 13 | n = 17 |
Median (range) | 9 (3–38) | 11 (2–22) |
Rate of fall in eGFR, ml/min/1.73m2/month | n = 13 | n = 17 |
Median (range) | 0.56 (0.06–5.40) | 0.29 (0.06–2.26) |
Fall in eGFR, > 30 ml/min/1.73m2 | n = 30 | n = 31 |
No. (%) | 2 (6%) | 0 (0%) |